The Australian market has shown resilience, with the ASX200 rising by 0.75% to 8,437 points, buoyed by positive developments such as China's measured response to tariffs and strong performances in the materials sector. In such a climate, investors often look beyond blue-chip stocks for opportunities that offer both growth and value potential. Penny stocks, though sometimes seen as a throwback to earlier trading days, remain relevant for those seeking companies with solid financials and hidden potential.
Name | Share Price | Market Cap | Financial Health Rating |
Embark Early Education (ASX:EVO) | A$0.79 | A$141.28M | ★★★★☆☆ |
LaserBond (ASX:LBL) | A$0.575 | A$66.82M | ★★★★★★ |
Austin Engineering (ASX:ANG) | A$0.50 | A$310.07M | ★★★★★☆ |
MaxiPARTS (ASX:MXI) | A$1.90 | A$106.21M | ★★★★★★ |
GTN (ASX:GTN) | A$0.535 | A$105.06M | ★★★★★★ |
Helloworld Travel (ASX:HLO) | A$1.94 | A$322.38M | ★★★★★★ |
SHAPE Australia (ASX:SHA) | A$3.00 | A$247.9M | ★★★★★★ |
IVE Group (ASX:IGL) | A$2.20 | A$334.56M | ★★★★☆☆ |
SKS Technologies Group (ASX:SKS) | A$1.59 | A$235.35M | ★★★★★★ |
Nickel Industries (ASX:NIC) | A$0.745 | A$3.2B | ★★★★★☆ |
Click here to see the full list of 1,032 stocks from our ASX Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Clover Corporation Limited produces, refines, and sells natural oils and encapsulated powders across Australia, New Zealand, Asia, Europe, the Middle East, and the Americas with a market cap of A$70.97 million.
Operations: The company generates revenue of A$62.21 million from its Nutritional Oil and Microencapsulated Powders segment.
Market Cap: A$70.97M
Clover Corporation Limited, with a market cap of A$70.97 million, operates in the nutritional oil and encapsulated powders segment, generating A$62.21 million in revenue. Despite its experienced management team and board, Clover has faced challenges with negative earnings growth over the past year (-75.6%) and declining profits over five years (24.1% annually). However, it maintains strong financial health with more cash than total debt and well-covered interest payments by EBIT (3.5x coverage). The company's short-term assets significantly exceed both short-term and long-term liabilities, providing a solid liquidity position despite low profit margins (2.4%).
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: First Graphene Limited focuses on the research, development, mining, exploration, manufacture, and sale of graphene products in Australia and the United Kingdom with a market cap of A$41.54 million.
Operations: The company's revenue is derived from Graphene Production, which accounts for A$0.30 million, and Research & Development, contributing A$0.19 million.
Market Cap: A$41.54M
First Graphene Limited, with a market cap of A$41.54 million, is pre-revenue, generating less than US$1 million annually from its graphene production and R&D activities. The company remains unprofitable but has been reducing losses over the past five years. Despite having more cash than total debt and short-term assets exceeding liabilities, First Graphene's cash runway is limited to less than a year if free cash flow grows at historical rates. Its board is experienced with an average tenure of 4.3 years, though management experience data is insufficient for assessment. Shareholders have not faced significant dilution recently.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Touch Ventures Limited is a private equity and venture capital firm focusing on growth capital for high-growth, post-revenue, and later-stage companies, with a market cap of A$53.84 million.
Operations: The company generates revenue through operating and managing investments in high-growth securities, amounting to A$38.07 million.
Market Cap: A$53.84M
Touch Ventures Limited, with a market cap of A$53.84 million, is pre-revenue, generating less than US$1 million annually. Despite being unprofitable and having negative return on equity (-46.05%), the company maintains a stable financial position with no debt and short-term assets (A$59.3M) exceeding liabilities (A$239K). It has sufficient cash runway for over three years if free cash flow continues to grow at historical rates. The board is experienced with an average tenure of 4.8 years, though management experience data is insufficient for assessment. Shareholders have not faced significant dilution recently despite earnings declines over five years.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:CLV ASX:FGR and ASX:TVL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.